ReViral
PITCH
ReViral is an emerging UK-based biotechnology company aiming to help patients and to enlarge the antiviral market by developing novel first-in-class compounds.
LATEST INVESTMENT
#biotech
08.2020
ReViral
£33.3M
CR-CP Life Science Fund, Andera Partners, Brace Pharma Capital, Green Sands Equity, New Leaf Venture Partners, Novo Holdings, OrbiMed Advisors, Perceptive Advisors